SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
-2.96%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$27.3B
AUM Growth
-$1.47B
(-5.1%)
Cap. Flow
+$18.4M
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
22.1%
Holding
2,295
New
116
Increased
639
Reduced
785
Closed
160
Top Buys
| 1 |
SIVB
SVB Financial Group
SIVB
|
+$57.1M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$55.8M |
| 3 |
PayPal
PYPL
|
+$46.4M |
| 4 |
Cencora
COR
|
+$42.9M |
| 5 |
Ameriprise Financial
AMP
|
+$42.9M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$118M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$104M |
| 3 |
The Mosaic Company
MOS
|
+$55M |
| 4 |
Willis Towers Watson
WTW
|
+$52M |
| 5 |
Meta Platforms (Facebook)
META
|
+$51.1M |
Sector Composition
| 1 | Technology | 24.53% |
| 2 | Financials | 14.74% |
| 3 | Healthcare | 12.18% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Real Estate | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Glaukos
GKOS
$5.02B
| $300K | ﹤0.01% |
5,200
| – | – |
|
1602
Marcus & Millichap
MMI
$1.26B
| $300K | ﹤0.01% |
5,700
| – | – |
|
1603
Palomar
PLMR
$3.18B
| $300K | ﹤0.01% |
+4,700
| New | +$300K |
|
1604
Protagonist Therapeutics
PTGX
$3.59B
| $300K | ﹤0.01% |
12,700
-500
| -4% | -$11.8K |
|
1605
Preformed Line Products
PLPC
$953M
| $298K | ﹤0.01% |
4,700
| – | – |
|
1606
Y-mAbs Therapeutics
YMAB
$390M
| $298K | ﹤0.01% |
+25,100
| New | +$298K |
|
1607
FTC Solar
FTCI
$94.3M
| $296K | ﹤0.01% |
6,020
| – | – |
|
|
FLIC
1608
DELISTED
First of Long Island Corp
FLIC
| $295K | ﹤0.01% |
15,200
| – | – |
|
1609
Community Bank
CBU
$3.13B
| $294K | ﹤0.01% |
4,200
+800
| +24% | +$56K |
|
1610
Independent Bank
INDB
$3.46B
| $294K | ﹤0.01% |
3,600
+1,000
| +38% | +$81.7K |
|
1611
Novo Nordisk
NVO
$242B
| $289K | ﹤0.01% |
5,208
-10,792
| -67% | -$599K |
|
1612
NETSCOUT
NTCT
$1.8B
| $288K | ﹤0.01% |
+9,000
| New | +$288K |
|
1613
CytomX Therapeutics
CTMX
$341M
| $285K | ﹤0.01% |
106,900
| – | – |
|
1614
Precision BioSciences
DTIL
$59.1M
| $285K | ﹤0.01% |
3,087
+2,130
| +223% | +$197K |
|
|
UCB
1615
United Community Banks, Inc.
UCB
$3.95B
| $285K | ﹤0.01% |
8,200
+3,400
| +71% | +$118K |
|
1616
NN Inc
NNBR
$121M
| $284K | ﹤0.01% |
98,800
| – | – |
|
1617
ProAssurance
PRA
$1.22B
| $284K | ﹤0.01% |
10,600
| – | – |
|
1618
MarketAxess Holdings
MKTX
$6.9B
| $283K | ﹤0.01% |
834
-182
| -18% | -$61.8K |
|
1619
Berry Corp
BRY
$251M
| $281K | ﹤0.01% |
27,300
-1,700
| -6% | -$17.5K |
|
|
RWT
1620
Redwood Trust
RWT
$801M
| $276K | ﹤0.01% |
26,300
| – | – |
|
1621
Designer Brands
DBI
$229M
| $275K | ﹤0.01% |
20,400
-14,700
| -42% | -$198K |
|
1622
Dynavax Technologies
DVAX
$1.14B
| $274K | ﹤0.01% |
25,300
| – | – |
|
1623
ACI Worldwide
ACIW
$5.17B
| $273K | ﹤0.01% |
8,700
+1,700
| +24% | +$53.3K |
|
1624
FuelCell Energy
FCEL
$130M
| $272K | ﹤0.01% |
1,577
+194
| +14% | +$33.5K |
|
1625
Taylor Morrison
TMHC
$6.89B
| $272K | ﹤0.01% |
10,000
+1,900
| +23% | +$51.7K |
|